+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Autotransfusion Devices Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797980
The global autotransfusion devices market size attained a value of USD 283.1 million in 2022. The market is anticipated to grow at a CAGR of 5.0% during the forecast period of 2023-2031 to attain a value of USD 439.2 million by 2031.

Autotransfusion Devices Market: Introduction

Autotransfusion devices are medical instruments used to collect, process, and return a patient's own blood during or after a surgical procedure. This process, known as autotransfusion or cell salvage, helps to minimize the need for allogeneic blood transfusions (blood from a donor) and reduce the risk of transfusion-related complications. The main uses and benefits of autotransfusion devices include:

1. Reduced reliance on donor blood: Autotransfusion reduces the need for allogeneic blood transfusions, which can help address blood shortages and decrease the demand on blood banks.
2. Lower risk of transfusion-related complications: Using a patient's own blood minimizes the risk of transfusion reactions, such as allergic reactions, haemolytic reactions, and transfusion-related acute lung injury (TRALI), as well as the transmission of blood-borne infections.
3. Improved patient outcomes: Autotransfusion can help to maintain optimal blood volume during surgery, reduce the risk of postoperative anaemia, and enhance overall patient outcomes.
4. Cost-effectiveness: By reducing the need for donor blood, autotransfusion can lead to cost savings for healthcare facilities and may help to lower the overall cost of surgical procedures.
5. Applicability in various surgeries: Autotransfusion devices are used in a wide range of surgical procedures where significant blood loss is expected, such as orthopaedic, cardiovascular, trauma, and transplant surgeries.
6. Preservation of blood components: The processing of blood through autotransfusion devices helps to maintain the integrity of blood components, such as red blood cells, platelets, and clotting factors, which can contribute to better patient outcomes.

In summary, autotransfusion devices are medical instruments that collect, process, and return a patient's own blood during or after surgery. Their use provides several benefits, including reduced reliance on donor blood, lower risk of transfusion-related complications, improved patient outcomes, cost-effectiveness, and applicability in various surgical procedures.

Autotransfusion Devices Market Segmentations

The market can be categorised into product type, application, end user, and region.

Market Breakup by Product type

  • Autotransfusion System
1. Intraoperative Autotransfusion System
2. Post-Operative Autotransfusion System
3. Dual-Mode Autotransfusion Systems
  • Consumables and Accessories

Market Breakup by Application

  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Organ Transplantation
  • Obstetrics and Gynecological Surgeries
  • Others

Market Breakup by End user

  • Hospitals
  • Specialty Clinics
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Autotransfusion Devices Market Scenario

The global autotransfusion devices market is driven by the increasing demand for medical instruments that reduce the reliance on allogeneic blood transfusions and enhance patient outcomes during surgical procedures. These devices are used in various surgeries, such as orthopaedic, cardiovascular, trauma, and transplant surgeries, where significant blood loss is expected. The market encompasses the development, production, distribution, and sales of autotransfusion devices, as well as research and development of new and improved technologies.

Market Drivers

Key factors propelling the autotransfusion devices market include the rising number of surgical procedures worldwide, technological advancements in medical devices, and the growing awareness of the benefits of autotransfusion. Additionally, the market is driven by the increasing prevalence of chronic diseases that may necessitate surgical intervention, a rising global aging population, and the need to address blood shortages in healthcare facilities.

Market Challenges

Despite the growing demand for autotransfusion devices, the market faces some challenges. High costs associated with these devices and the requirement for skilled professionals to operate them may limit their adoption, particularly in low- and middle-income countries where healthcare resources are constrained. Furthermore, the lack of awareness regarding autotransfusion devices in some regions may hinder market growth.

Regional Analysis

Geographically, the global autotransfusion devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominates the market due to its advanced healthcare infrastructure, increased adoption of advanced medical devices, and the presence of key market players. Europe follows closely, while Asia-Pacific is anticipated to be the fastest-growing region due to the increasing prevalence of chronic diseases, improving healthcare infrastructure, and rising healthcare expenditures in the region.

Future Outlook

The autotransfusion devices market is expected to continue growing in the coming years, primarily driven by the increasing number of surgical procedures, technological advancements, and the need to reduce reliance on allogeneic blood transfusions. As new technologies emerge and healthcare systems continue to evolve, the market may experience increased access to autotransfusion devices, leading to improved surgical outcomes and enhanced patient care worldwide.

Key Players in the Global Autotransfusion Devices Market

The report gives an in-depth analysis of the key players involved in the autotransfusion devices market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • LivaNova PLC
  • Haemonetics Corporation
  • Medtronic plc
  • Fresenius SE & Co. KGaA
  • Becton, Dickinson, and Company (BD)
  • Redax
  • Haemonetics Corporation
  • Braile Biomedica
  • Gen world Medical Devices
  • Teleflex Incorporated
  • Zimmer Biomet Holdings Inc.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Autotransfusion Devices Market Overview
3.1 Global Autotransfusion Devices Market Historical Value (2016-2022)
3.2 Global Autotransfusion Devices Market Forecast Value (2023-2031)
4 Global Autotransfusion Devices Market Landscape
4.1 Global Autotransfusion Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Autotransfusion Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global Autotransfusion Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Autotransfusion Devices Market Segmentation
6.1 Global Autotransfusion Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Autotransfusion System Intraoperative Autotransfusion System Post-Operative Autotransfusion System Dual-Mode Autotransfusion Systems
6.1.3 Consumables and Accessories
6.2 Global Autotransfusion Devices Market by Application
6.2.1 Market Overview
6.2.2 Cardiovascular Surgeries
6.2.3 Orthopaedic Surgeries
6.2.4 Neurological Surgeries
6.2.5 Organ Transplantation
6.2.6 Obstetrics and Gynaecological Surgeries
6.2.7 Others
6.3 Global Autotransfusion Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Others
6.4 Global Autotransfusion Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Autotransfusion Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Autotransfusion Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Autotransfusion Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Autotransfusion Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Autotransfusion Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 LivaNova PLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Haemonetics Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Medtronic plc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Fresenius SE & Co. KGaA
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Becton, Dickinson, and Company (BD)
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Redax
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Haemonetics Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Braile Biomedica
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Gen world Medical Devices
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 SARSTEDT AG & CO. Kg
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Teleflex Incorporated
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Zimmer Biomet Holdings Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Autotransfusion Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Livanova plc
  • Haemonetics Corporation
  • Medtronic plc
  • Fresenius Se & Co. Kgaa
  • Becton, Dickinson, and Company (Bd)
  • Redax
  • Haemonetics Corporation
  • Braile Biomedica
  • Gen World Medical Devices
  • Sarstedt AG & Co. Kg
  • Teleflex Incorporated
  • Zimmer Biomet Holdings Inc.



Table Information